TBCRC 048 UAB 1846: A Phase 2 Study of Olaparib Monotherapy in Metastatic Breast Cancer Patients with Germline or Somatic Mutations in DNA Repair Genes

Grant

Date/time Interval

  • December 19, 2018 - December 18, 2023
  • Total Award Amount

  • 129461.00
  • Direct Costs

  • 99585.00
  • Sponsor Award Id

  • Contributor

  • Rocque M.D., Gabrielle   Investigator  
  • Stringer-Reasor M.D., Erica   Investigator